FSH‑rec (Gonal‑F / Puregon)
Prescription fertility hormone (FSH) that athletes who have used steroids try in order to restart sperm production; banned in sport.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Related comparisons
HCG vs HMG vs FSH-recDETAILED OVERVIEW
What is FSH-rec (Gonal-F / Puregon)?
FSH-rec (Gonal-F, Puregon) is an FSH hormone made in a lab using hamster cells, a prescription medicine used in fertility treatment. In men, FSH supports sperm production. After long steroid use, when sperm production stops, bodybuilders try it to get production going again. It is banned year-round in competitive sport.
It acts only on the cells in the testicle that support sperm production. It does not stimulate the cells that make testosterone, because it lacks the effect of LH, the hormone that triggers testosterone production, so it is usually used together with a hormone called HCG. The most common side effects are redness and pain at the injection site and headache; rarely, a severe allergic reaction or a blood clot can occur. It does not work if the testicle is faulty to begin with (for example in Klinefelter syndrome), and it cannot be used with hormone-dependent tumors. For men, only a few studies exist on the effect athletes hope for, mostly in patients with hormone deficiency.
Mechanism
Lab-made FSH; stimulates only Sertoli cells, with no LH activity
Half-life
~24-36 hours (recombinant)
Onset
Inhibin-B rise 2-4 weeks, sperm count rise 3-9 months
Legal status
EMA Rx Gonal-F (1995) + Puregon (1996), FDA Rx (1997), WADA S2 (banned)
No anecdote collected yet.
Data console
Lab data
Grob F, Keshwani R, Angley E . Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone.. J Paediatr Child Health.
Mao J, Xu H, Wang X, Wu X, Nie M, Zhang H, Han B, Liu Z, Zhang K, Lian S, Lu S, Wang X, Chen N, Sun B, Liu J, Cui Q . Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.. Hum Reprod.
Zacharin M, Sabin MA, Nair VV, Nicolaides R . Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.. Fertil Steril.
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Injection-site reactions: redness, pain, itching, swelling and bruising at the SC injection site (the most common adverse effect).
- Headache, the most common systemic complaint during treatment.
- Hypersensitivity / allergic reactions: rash, urticaria, as a response to residual CHO-cell-derived proteins; rarely severe anaphylactic reactions may occur.
- Gastrointestinal symptoms: nausea, abdominal pain, diarrhea and bloating.
- In men (on long HCG + FSH-rec protocols) gynecomastia and acne may occur, mainly due to the testosterone and estrogen rise driven by the co-administered HCG, not by FSH itself.
- Thromboembolic events (deep vein thrombosis, pulmonary embolism) are a rare but serious risk, mainly in the presence of predisposing factors (thrombophilia, obesity, prior thrombosis).
- Ovarian hyperstimulation syndrome (OHSS) – relevant only in female fertility use: abdominal distension, ovarian enlargement, in severe cases fluid accumulation; not applicable to male protocols.
Contraindications · 6
- Pituitary or hypothalamic tumor, or undiagnosed, untreated endocrine disorder (thyroid, adrenal).
- Hypersensitivity to follitropin, to CHO-cell-derived residual proteins, or to any excipient of the product.
- Tumors of the reproductive organs, or a hormone-dependent tumor of the testes (or in women the ovary, breast, uterus).
- Primary testicular failure (e.g. Klinefelter syndrome, Y-chromosome AZF microdeletion) – here the Sertoli defect is primary and FSH-rec is ineffective.
- Active thromboembolic disease or high thrombotic risk (severe thrombophilia, recent thrombosis).
- WADA S2.2 prohibited substance – banned year-round for competing athletes (both in- and out-of-competition).
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Fertility outcomes in male adults with congenital hypogonadotropic hypogonadism treated during puberty with human chorionic gonadotropin and recombinant follicle stimulating hormone.
Grob F, Keshwani R, Angley E
Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
Mao J, Xu H, Wang X, Wu X, Nie M, Zhang H, Han B, Liu Z, Zhang K, Lian S, Lu S, Wang X, Chen N, Sun B, Liu J, Cui Q
Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
Zacharin M, Sabin MA, Nair VV, Nicolaides R
Telegram
Have a question about FSH‑rec (Gonal‑F / Puregon)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.
